Member Info for BuenaVista

Do me! Do me! I'm sure it would say I'm a twat who can't spell or write proper sentences.

If anyone thinks investors meeting with Avacta management won't have had more information than what has been stated in official RNS then they are fools.

If BG were selling based on initial Phase 1b data then that would be insider trading and if Avacta had given them that information whilst on Nasdaq, the legal vultures in the US would be suing them to boggery.

If based on Phase 1a data then that could be because BG saw better and quicker returns elsewhere, their own expectations (even knowing these were often heavily pretreated patients?) weren't met, or Avacta not being a US company counted against them in Trumpland. That last one is a definite possibility if the US market is lost.

What are you guys on about?

This relates to AVA04, an Affimer that has been dropped from the Avacta pipeline. These market reports are expensive but typically comprehensively out of date.

I think the Avacta board need you on the team VR as you are so obviously a master strategist with globular noledge and infective incision mocking skulls.

Well obviously BP are not going to move until Phase 1b starts showing definite results, which should be around about now and continuing into the summer months. Hopefully Avacta will be able to get at least a small deal over the line in time to support the share price and cash runway going into at least Q2 next year ...maybe a deal peripheral to current strategy such as funding Phase 1b development of AVA6000 in ovarian cancer - with extra cash to support the current Phase 1b indications through to completion. Really, the licensing and partnership deal options are myriad.

So the usual Eggy arguments, based on nothing more than TW's handout of usual arguments. Tell TW he must try harder; be creative, be original.

Avacta hugely undervalued, wyndbag hugely overinflated.

With your level of patience I suggest you concentrate on fruit machines in future rather than paying around with biotech companies. Face it: you thought you'd buy in and make a quick killing and now you find yourself deeply underwater and locked in. Just take it as a life lesson, and if you make the effort to understand what you're 'invested' in you'll realise that this company is hugely undervalued.

Be fair Timmy. It probably made sense in Danish.

You can create clickable links by using tinyurl.com

Yeah, just curious as to how many would give a rec to a complete load of mindless drivel, subtext: you're gonna be rich soon, from the HurstBot Dictionary of B*ll"cks. Was going down well until CJ blew my cover.

The market turmoil has ended now that President Trump has settled the tariff levies and industry will start to power ahead including BP who have cash burning holes in their pockets ahead of M&A and IPOs. Avacta ready to take advantage of this situation, starting with AACR 25 at the end of the month where CC and team will meet with Novartis and Pfizer representatives amongst others and be agreeing deals. Size buyers NY from open.

Double clown

Yes very astute, like my question at the December 2023 review of AVA6000 clinical data (Question 5):

"Are you investigating genetic typing (e.g. using AI) to determine which cancers are likely to be best treated with pre|CISION drugs and which side effects are likely for which patients?"

Well they've done the first part.

Btw, great new word: 'proberly', a combination of probably and properly. Very astute use of English.

Clown

Yes WF, the bond market will dominate the policy. When Japan started selling off US Treasuries and the bond yield rose to 4.5%, that meant the US would have to find c$300bn extra to pay the interest and Trump caved. This is the sword that China and the EU hold over Trump.

Still, Trump has, by his own words, been gathering in $2bn a day and it wouldn't be like him to pass up the opportunity of gathering in a bit more.

For context: $Trump is a meme coin associated with U.S. President Donald Trump, hosted on the Solana blockchain platform. One billion coins were originally created; 800 million remain owned by two Trump-owned companies, after 200 million were publicly released in an initial coin offering on January 17, 2025.

This is absolutely not a vehicle for bribery and corruption.

By 'lobby' I guess you mean let Trump know that they're just about to purchase $bns of $TRUMPs?

"She has nearly four years worth of positive in - clinic data in her handbag, yet she is incapable of selling it , she doesn’t possess the skillset."

Moving swiftly over the misogyny, although I don't discount that as the root of your antagonism towards her, what skillset do you think she doesn't possess? ...Bearing in mind that the people she, and Simon Bennett, are 'selling' to are extremely knowledgeable and sophisticated people, responsible for very large budgets, not the crowd buying spuds down at the local market.